Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnetic Resonance Angiography | 14 | 2015 | 1442 | 1.500 |
Why?
|
Pulmonary Veins | 10 | 2015 | 761 | 1.270 |
Why?
|
Heart Atria | 9 | 2013 | 1357 | 0.830 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 4 | 2023 | 220 | 0.740 |
Why?
|
Salicylates | 2 | 2017 | 126 | 0.690 |
Why?
|
Atrial Fibrillation | 15 | 2018 | 5034 | 0.670 |
Why?
|
Magnetic Resonance Imaging, Cine | 10 | 2019 | 964 | 0.670 |
Why?
|
Spironolactone | 1 | 2021 | 382 | 0.600 |
Why?
|
Myocardial Perfusion Imaging | 5 | 2021 | 554 | 0.560 |
Why?
|
Catheter Ablation | 7 | 2015 | 2758 | 0.520 |
Why?
|
Technetium Tc 99m Sestamibi | 2 | 2013 | 177 | 0.490 |
Why?
|
Phlebography | 1 | 2015 | 333 | 0.480 |
Why?
|
Magnetic Resonance Imaging | 22 | 2023 | 35421 | 0.460 |
Why?
|
Contrast Media | 12 | 2016 | 5300 | 0.450 |
Why?
|
Gadolinium DTPA | 5 | 2012 | 836 | 0.430 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2015 | 693 | 0.420 |
Why?
|
Atrial Flutter | 2 | 2004 | 263 | 0.390 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2019 | 2016 | 0.390 |
Why?
|
Personnel, Hospital | 1 | 2013 | 283 | 0.380 |
Why?
|
Atrial Function, Left | 2 | 2011 | 173 | 0.380 |
Why?
|
Imaging, Three-Dimensional | 11 | 2023 | 4042 | 0.370 |
Why?
|
Cicatrix | 4 | 2013 | 764 | 0.350 |
Why?
|
Image Interpretation, Computer-Assisted | 7 | 2014 | 3327 | 0.350 |
Why?
|
Image Enhancement | 10 | 2014 | 2921 | 0.350 |
Why?
|
Head and Neck Neoplasms | 2 | 2014 | 2734 | 0.340 |
Why?
|
Arrhythmias, Cardiac | 4 | 2021 | 2268 | 0.340 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2004 | 789 | 0.340 |
Why?
|
Overweight | 2 | 2017 | 2371 | 0.320 |
Why?
|
Microscopic Polyangiitis | 2 | 2023 | 45 | 0.320 |
Why?
|
Coronary Vessels | 4 | 2010 | 3107 | 0.320 |
Why?
|
Immunosuppressive Agents | 5 | 2015 | 4149 | 0.320 |
Why?
|
Artifacts | 6 | 2020 | 1904 | 0.310 |
Why?
|
Coronary Artery Disease | 11 | 2021 | 6487 | 0.310 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2014 | 4034 | 0.300 |
Why?
|
Ventricular Function, Left | 8 | 2021 | 3670 | 0.290 |
Why?
|
Losartan | 1 | 2008 | 299 | 0.280 |
Why?
|
Electrocardiography | 12 | 2021 | 6442 | 0.280 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2282 | 0.270 |
Why?
|
Cerebrovascular Disorders | 1 | 2013 | 1504 | 0.270 |
Why?
|
Cerebrovascular Circulation | 2 | 2013 | 2731 | 0.270 |
Why?
|
Exercise Test | 4 | 2019 | 2074 | 0.260 |
Why?
|
Coronary Disease | 7 | 2022 | 6077 | 0.260 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2008 | 451 | 0.260 |
Why?
|
Amiodarone | 2 | 2004 | 212 | 0.260 |
Why?
|
Outpatients | 3 | 2015 | 1486 | 0.260 |
Why?
|
Myocardial Contraction | 2 | 2011 | 1585 | 0.260 |
Why?
|
Pulmonary Veno-Occlusive Disease | 1 | 2005 | 66 | 0.250 |
Why?
|
Middle Aged | 61 | 2023 | 213383 | 0.250 |
Why?
|
Coronary Thrombosis | 1 | 2008 | 495 | 0.250 |
Why?
|
Radiation Dosage | 1 | 2013 | 1928 | 0.250 |
Why?
|
Plaque, Atherosclerotic | 1 | 2016 | 1519 | 0.250 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 5 | 2019 | 1107 | 0.240 |
Why?
|
Heart | 5 | 2020 | 4467 | 0.240 |
Why?
|
Predictive Value of Tests | 14 | 2021 | 15076 | 0.240 |
Why?
|
Churg-Strauss Syndrome | 1 | 2004 | 70 | 0.240 |
Why?
|
Pulmonary Eosinophilia | 1 | 2004 | 82 | 0.230 |
Why?
|
Leukotriene Antagonists | 1 | 2004 | 127 | 0.230 |
Why?
|
Neovascularization, Pathologic | 1 | 2014 | 2635 | 0.230 |
Why?
|
Male | 72 | 2023 | 350118 | 0.230 |
Why?
|
Cardiac Volume | 1 | 2004 | 210 | 0.220 |
Why?
|
Acetates | 1 | 2004 | 311 | 0.220 |
Why?
|
Radiographic Image Enhancement | 2 | 2007 | 885 | 0.220 |
Why?
|
Lymph Nodes | 1 | 2014 | 3474 | 0.210 |
Why?
|
B-Lymphocytes | 2 | 2015 | 4665 | 0.210 |
Why?
|
Aged | 43 | 2023 | 163280 | 0.210 |
Why?
|
Ventricular Dysfunction, Left | 5 | 2019 | 2073 | 0.210 |
Why?
|
Angina Pectoris | 2 | 2019 | 977 | 0.200 |
Why?
|
Obesity | 5 | 2016 | 12745 | 0.200 |
Why?
|
Adenocarcinoma | 1 | 2019 | 6364 | 0.200 |
Why?
|
Patient Identification Systems | 1 | 2001 | 79 | 0.200 |
Why?
|
Echocardiography, Doppler | 3 | 2019 | 935 | 0.200 |
Why?
|
Female | 68 | 2021 | 380194 | 0.190 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2013 | 2737 | 0.190 |
Why?
|
Defibrillators, Implantable | 4 | 2015 | 1440 | 0.190 |
Why?
|
Coronary Angiography | 9 | 2021 | 4577 | 0.190 |
Why?
|
Humans | 90 | 2023 | 744343 | 0.190 |
Why?
|
Sensitivity and Specificity | 11 | 2014 | 14722 | 0.180 |
Why?
|
Gadolinium | 4 | 2013 | 952 | 0.180 |
Why?
|
Aortic Valve Insufficiency | 2 | 2019 | 579 | 0.180 |
Why?
|
Soccer | 1 | 2021 | 133 | 0.170 |
Why?
|
Blood Flow Velocity | 3 | 2013 | 1423 | 0.170 |
Why?
|
Leg Injuries | 1 | 2021 | 178 | 0.170 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2022 | 3255 | 0.170 |
Why?
|
Myocardium | 4 | 2018 | 4776 | 0.170 |
Why?
|
Myocardial Ischemia | 2 | 2013 | 2148 | 0.170 |
Why?
|
Quinolines | 1 | 2004 | 732 | 0.170 |
Why?
|
Reproducibility of Results | 11 | 2019 | 19905 | 0.170 |
Why?
|
Antihypertensive Agents | 1 | 2008 | 2046 | 0.170 |
Why?
|
Glucose Transporter Type 1 | 1 | 2019 | 192 | 0.170 |
Why?
|
Chromosomes, Human, Pair 9 | 2 | 2012 | 535 | 0.160 |
Why?
|
Cardiomyopathies | 3 | 2021 | 1912 | 0.160 |
Why?
|
Stroke Volume | 5 | 2021 | 5007 | 0.160 |
Why?
|
Kidney Diseases | 3 | 2022 | 2149 | 0.150 |
Why?
|
Ventricular Remodeling | 2 | 2019 | 1224 | 0.150 |
Why?
|
Treatment Outcome | 17 | 2019 | 63114 | 0.140 |
Why?
|
Heart Failure | 1 | 2021 | 10900 | 0.140 |
Why?
|
Adult | 38 | 2023 | 214055 | 0.140 |
Why?
|
Stents | 2 | 2008 | 3280 | 0.140 |
Why?
|
Cardiac-Gated Imaging Techniques | 3 | 2013 | 143 | 0.140 |
Why?
|
Lectins | 1 | 2019 | 513 | 0.140 |
Why?
|
Diabetic Angiopathies | 2 | 2012 | 818 | 0.140 |
Why?
|
Inflammation | 1 | 2016 | 10638 | 0.140 |
Why?
|
Hypertrophy, Left Ventricular | 3 | 2018 | 859 | 0.140 |
Why?
|
Cardiomyopathy, Hypertrophic | 3 | 2011 | 1265 | 0.140 |
Why?
|
Cardiac Imaging Techniques | 1 | 2018 | 269 | 0.130 |
Why?
|
Tomography, X-Ray Computed | 8 | 2015 | 20129 | 0.130 |
Why?
|
Sarcoidosis | 1 | 2021 | 506 | 0.130 |
Why?
|
Tachycardia, Sinus | 1 | 2015 | 42 | 0.130 |
Why?
|
Diabetes Mellitus, Type 2 | 7 | 2013 | 11725 | 0.130 |
Why?
|
Coronary Stenosis | 1 | 2021 | 834 | 0.130 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2008 | 3068 | 0.130 |
Why?
|
Respiratory-Gated Imaging Techniques | 2 | 2012 | 71 | 0.130 |
Why?
|
Mycophenolic Acid | 2 | 2022 | 343 | 0.130 |
Why?
|
Tachycardia, Ventricular | 2 | 2015 | 1273 | 0.120 |
Why?
|
Prospective Studies | 15 | 2023 | 53288 | 0.120 |
Why?
|
Mitral Valve Prolapse | 1 | 2016 | 231 | 0.120 |
Why?
|
Image Processing, Computer-Assisted | 8 | 2020 | 8949 | 0.120 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 2019 | 2104 | 0.120 |
Why?
|
Meglumine | 2 | 2013 | 149 | 0.120 |
Why?
|
Pericardium | 1 | 2018 | 667 | 0.120 |
Why?
|
Electrocardiography, Ambulatory | 3 | 2011 | 585 | 0.120 |
Why?
|
Glutamate-Ammonia Ligase | 1 | 2013 | 74 | 0.110 |
Why?
|
Molecular Imaging | 1 | 2020 | 828 | 0.110 |
Why?
|
Fats | 1 | 2014 | 102 | 0.110 |
Why?
|
Coronary Aneurysm | 2 | 2008 | 237 | 0.110 |
Why?
|
Heart Valves | 1 | 2015 | 291 | 0.110 |
Why?
|
Genetic Association Studies | 3 | 2019 | 2703 | 0.110 |
Why?
|
Hypertension | 3 | 2011 | 8480 | 0.110 |
Why?
|
Lymphocyte Depletion | 1 | 2015 | 608 | 0.110 |
Why?
|
Chest Pain | 2 | 2012 | 1114 | 0.110 |
Why?
|
Allergy and Immunology | 1 | 2014 | 169 | 0.110 |
Why?
|
Radiopharmaceuticals | 3 | 2019 | 2645 | 0.100 |
Why?
|
Alzheimer Disease | 1 | 2013 | 8037 | 0.100 |
Why?
|
Recurrence | 4 | 2015 | 8340 | 0.100 |
Why?
|
Time Factors | 10 | 2015 | 40075 | 0.100 |
Why?
|
Multivariate Analysis | 4 | 2015 | 12245 | 0.100 |
Why?
|
Supine Position | 2 | 2019 | 205 | 0.100 |
Why?
|
Motion | 2 | 2013 | 798 | 0.100 |
Why?
|
Prediabetic State | 1 | 2017 | 499 | 0.100 |
Why?
|
Remission Induction | 2 | 2015 | 2386 | 0.100 |
Why?
|
Renal Dialysis | 1 | 2021 | 1786 | 0.100 |
Why?
|
Athletic Injuries | 1 | 2021 | 1154 | 0.100 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2013 | 658 | 0.100 |
Why?
|
Hemoptysis | 1 | 2012 | 155 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 4 | 2015 | 6538 | 0.100 |
Why?
|
Organometallic Compounds | 2 | 2013 | 665 | 0.090 |
Why?
|
Nephrology | 1 | 2014 | 263 | 0.090 |
Why?
|
Pyrophosphatases | 1 | 2011 | 137 | 0.090 |
Why?
|
Cholesterol, HDL | 2 | 2022 | 1814 | 0.090 |
Why?
|
Databases, Factual | 3 | 2016 | 7729 | 0.090 |
Why?
|
Coronary Circulation | 2 | 2013 | 1572 | 0.090 |
Why?
|
Mortality | 1 | 2001 | 2864 | 0.090 |
Why?
|
General Practice | 1 | 2011 | 100 | 0.090 |
Why?
|
Boston | 6 | 2016 | 9313 | 0.090 |
Why?
|
Acute Coronary Syndrome | 2 | 2015 | 2337 | 0.090 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2011 | 197 | 0.090 |
Why?
|
Switzerland | 2 | 2014 | 255 | 0.090 |
Why?
|
Electric Countershock | 1 | 2013 | 534 | 0.090 |
Why?
|
Troponin T | 1 | 2015 | 754 | 0.090 |
Why?
|
Early Diagnosis | 1 | 2015 | 1184 | 0.090 |
Why?
|
Glomerular Filtration Rate | 3 | 2012 | 2170 | 0.090 |
Why?
|
Surgery, Computer-Assisted | 2 | 2008 | 1018 | 0.090 |
Why?
|
Pilot Projects | 5 | 2019 | 8324 | 0.090 |
Why?
|
Echocardiography | 2 | 2013 | 5102 | 0.090 |
Why?
|
Aortic Valve | 1 | 2019 | 1922 | 0.090 |
Why?
|
Bone Marrow Transplantation | 2 | 2007 | 2765 | 0.090 |
Why?
|
Vascular System Injuries | 1 | 2013 | 250 | 0.090 |
Why?
|
Azathioprine | 1 | 2010 | 353 | 0.080 |
Why?
|
Prognosis | 6 | 2023 | 29063 | 0.080 |
Why?
|
Algorithms | 7 | 2018 | 13881 | 0.080 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2011 | 563 | 0.080 |
Why?
|
Primary Prevention | 2 | 2013 | 1167 | 0.080 |
Why?
|
Retrospective Studies | 13 | 2019 | 77449 | 0.080 |
Why?
|
Echocardiography, Transesophageal | 1 | 2015 | 1133 | 0.080 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2011 | 689 | 0.080 |
Why?
|
Rheumatology | 1 | 2014 | 576 | 0.080 |
Why?
|
Aged, 80 and over | 10 | 2014 | 57776 | 0.080 |
Why?
|
Albuminuria | 1 | 2012 | 682 | 0.080 |
Why?
|
Observer Variation | 3 | 2019 | 2593 | 0.080 |
Why?
|
Mitral Valve Insufficiency | 2 | 2010 | 1422 | 0.080 |
Why?
|
Severity of Illness Index | 9 | 2019 | 15540 | 0.080 |
Why?
|
Magnetics | 1 | 2011 | 606 | 0.080 |
Why?
|
Glutamic Acid | 1 | 2013 | 1169 | 0.080 |
Why?
|
Fatty Liver | 1 | 2014 | 727 | 0.080 |
Why?
|
Cyclophosphamide | 2 | 2010 | 2242 | 0.080 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2010 | 356 | 0.080 |
Why?
|
Myocardial Infarction | 3 | 2015 | 11727 | 0.070 |
Why?
|
Statistics, Nonparametric | 3 | 2012 | 2886 | 0.070 |
Why?
|
Internal Medicine | 1 | 2014 | 1009 | 0.070 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2007 | 110 | 0.070 |
Why?
|
Glucose | 1 | 2019 | 4397 | 0.070 |
Why?
|
Heart Valve Diseases | 1 | 2015 | 1073 | 0.070 |
Why?
|
Tumor Burden | 1 | 2013 | 1915 | 0.070 |
Why?
|
Respiratory Mechanics | 1 | 2011 | 686 | 0.070 |
Why?
|
Aortic Diseases | 1 | 2013 | 742 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 4 | 2019 | 17446 | 0.070 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2006 | 141 | 0.070 |
Why?
|
Diastole | 2 | 2011 | 791 | 0.070 |
Why?
|
Brain | 1 | 2013 | 26385 | 0.070 |
Why?
|
Adipose Tissue | 1 | 2018 | 3279 | 0.070 |
Why?
|
Feasibility Studies | 4 | 2019 | 5078 | 0.070 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2008 | 272 | 0.070 |
Why?
|
Lymphatic Metastasis | 1 | 2014 | 2924 | 0.070 |
Why?
|
Risk Factors | 11 | 2017 | 72290 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2013 | 15519 | 0.070 |
Why?
|
Double-Blind Method | 2 | 2017 | 12026 | 0.070 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2011 | 531 | 0.070 |
Why?
|
Positron-Emission Tomography | 2 | 2019 | 6234 | 0.060 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2006 | 235 | 0.060 |
Why?
|
Italy | 3 | 2011 | 832 | 0.060 |
Why?
|
Aorta | 1 | 2013 | 2061 | 0.060 |
Why?
|
Thallium | 1 | 2004 | 101 | 0.060 |
Why?
|
Death, Sudden, Cardiac | 1 | 2013 | 1541 | 0.060 |
Why?
|
Guideline Adherence | 1 | 2015 | 2266 | 0.060 |
Why?
|
Incidental Findings | 1 | 2009 | 689 | 0.060 |
Why?
|
Cardiovascular Diseases | 4 | 2017 | 15165 | 0.060 |
Why?
|
Lung Diseases | 2 | 2012 | 1886 | 0.060 |
Why?
|
Registries | 2 | 2015 | 8089 | 0.060 |
Why?
|
Diabetes Complications | 1 | 2011 | 1359 | 0.060 |
Why?
|
Prone Position | 1 | 2005 | 194 | 0.060 |
Why?
|
Heart Rate | 1 | 2015 | 4091 | 0.060 |
Why?
|
Carotid Artery Diseases | 1 | 2010 | 882 | 0.060 |
Why?
|
Body Size | 1 | 2006 | 461 | 0.060 |
Why?
|
Sulfides | 1 | 2004 | 165 | 0.060 |
Why?
|
Myocardial Revascularization | 1 | 2007 | 841 | 0.060 |
Why?
|
Risk Assessment | 8 | 2019 | 23338 | 0.060 |
Why?
|
Drug Therapy, Combination | 3 | 2014 | 6489 | 0.060 |
Why?
|
Acute Disease | 3 | 2008 | 7149 | 0.060 |
Why?
|
Triglycerides | 1 | 2011 | 2454 | 0.050 |
Why?
|
Heart Conduction System | 1 | 2008 | 1047 | 0.050 |
Why?
|
Cyclopropanes | 1 | 2004 | 416 | 0.050 |
Why?
|
Blood Glucose | 1 | 2017 | 6256 | 0.050 |
Why?
|
Young Adult | 9 | 2021 | 56430 | 0.050 |
Why?
|
Case-Control Studies | 7 | 2019 | 21746 | 0.050 |
Why?
|
Movement | 2 | 2011 | 1471 | 0.050 |
Why?
|
Postoperative Care | 1 | 2009 | 1486 | 0.050 |
Why?
|
Social Security | 1 | 2001 | 101 | 0.050 |
Why?
|
Bradycardia | 1 | 2003 | 307 | 0.050 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2023 | 288 | 0.050 |
Why?
|
Radiosurgery | 1 | 2010 | 1329 | 0.050 |
Why?
|
Antirheumatic Agents | 1 | 2010 | 1339 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2011 | 2916 | 0.050 |
Why?
|
Apolipoprotein A-I | 1 | 2022 | 281 | 0.050 |
Why?
|
Laser Therapy | 1 | 2007 | 1072 | 0.050 |
Why?
|
Ambulatory Care | 1 | 2011 | 2708 | 0.050 |
Why?
|
Incidence | 4 | 2011 | 20947 | 0.050 |
Why?
|
Hemorrhage | 1 | 2012 | 3461 | 0.050 |
Why?
|
Cardiology | 1 | 2011 | 1668 | 0.040 |
Why?
|
Follow-Up Studies | 7 | 2015 | 39050 | 0.040 |
Why?
|
Coronary Vessel Anomalies | 1 | 2003 | 314 | 0.040 |
Why?
|
Graft Occlusion, Vascular | 1 | 2003 | 549 | 0.040 |
Why?
|
Genotype | 4 | 2019 | 12951 | 0.040 |
Why?
|
Radionuclide Imaging | 3 | 2013 | 2031 | 0.040 |
Why?
|
Bariatric Surgery | 1 | 2009 | 952 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 7913 | 0.040 |
Why?
|
Biopsy, Needle | 1 | 2004 | 1641 | 0.040 |
Why?
|
Linear Models | 2 | 2011 | 5952 | 0.040 |
Why?
|
Postoperative Complications | 2 | 2013 | 15295 | 0.040 |
Why?
|
Purines | 1 | 2021 | 594 | 0.040 |
Why?
|
Liver | 1 | 2014 | 7474 | 0.040 |
Why?
|
Chi-Square Distribution | 1 | 2004 | 3508 | 0.040 |
Why?
|
Logistic Models | 3 | 2011 | 13408 | 0.040 |
Why?
|
Radiography, Thoracic | 1 | 2004 | 1265 | 0.040 |
Why?
|
Weight Loss | 1 | 2009 | 2622 | 0.040 |
Why?
|
Coronary Artery Bypass | 2 | 2007 | 2289 | 0.040 |
Why?
|
Biological Transport | 1 | 2022 | 2118 | 0.040 |
Why?
|
Adolescent | 7 | 2023 | 85781 | 0.040 |
Why?
|
Cross-Sectional Studies | 5 | 2023 | 25043 | 0.040 |
Why?
|
Insulin Resistance | 1 | 2011 | 3864 | 0.040 |
Why?
|
Cognition | 1 | 2014 | 6770 | 0.040 |
Why?
|
Lipoproteins | 1 | 2022 | 878 | 0.040 |
Why?
|
Patient Positioning | 1 | 2019 | 324 | 0.040 |
Why?
|
Kidney | 1 | 2012 | 7186 | 0.030 |
Why?
|
Heart Diseases | 1 | 2009 | 2788 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5751 | 0.030 |
Why?
|
Recovery of Function | 2 | 2019 | 2925 | 0.030 |
Why?
|
Infusions, Intravenous | 2 | 2010 | 2274 | 0.030 |
Why?
|
Heart Ventricles | 1 | 2007 | 3821 | 0.030 |
Why?
|
Chronic Disease | 3 | 2019 | 9146 | 0.030 |
Why?
|
Blood Sedimentation | 1 | 2014 | 231 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2010 | 9274 | 0.030 |
Why?
|
Equipment Design | 2 | 2011 | 3582 | 0.030 |
Why?
|
Blood Pressure | 1 | 2008 | 8554 | 0.030 |
Why?
|
Cholesterol | 1 | 2022 | 2917 | 0.030 |
Why?
|
Placebos | 1 | 2017 | 1676 | 0.030 |
Why?
|
Phenotype | 3 | 2019 | 16365 | 0.030 |
Why?
|
Proportional Hazards Models | 3 | 2013 | 12354 | 0.030 |
Why?
|
Respiration | 2 | 2011 | 1653 | 0.030 |
Why?
|
Water | 1 | 2018 | 1395 | 0.030 |
Why?
|
Genetic Testing | 2 | 2019 | 3444 | 0.030 |
Why?
|
Hong Kong | 1 | 2011 | 148 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2013 | 6895 | 0.030 |
Why?
|
Pyrazoles | 1 | 2021 | 1972 | 0.020 |
Why?
|
Atherosclerosis | 1 | 2007 | 3445 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3176 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2003 | 10943 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2004 | 11366 | 0.020 |
Why?
|
Cardiac Resynchronization Therapy Devices | 1 | 2011 | 124 | 0.020 |
Why?
|
Glutamine | 1 | 2013 | 578 | 0.020 |
Why?
|
Carotid Artery, Internal, Dissection | 1 | 2010 | 45 | 0.020 |
Why?
|
Survival Analysis | 1 | 2003 | 10252 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2018 | 2480 | 0.020 |
Why?
|
Cohort Studies | 3 | 2011 | 40561 | 0.020 |
Why?
|
Glomerulonephritis | 1 | 2012 | 372 | 0.020 |
Why?
|
Utilization Review | 1 | 2011 | 392 | 0.020 |
Why?
|
Prednisolone | 1 | 2010 | 334 | 0.020 |
Why?
|
Lung | 2 | 2007 | 9856 | 0.020 |
Why?
|
Fibrosis | 1 | 2016 | 2029 | 0.020 |
Why?
|
Internet | 1 | 2001 | 3064 | 0.020 |
Why?
|
Intention to Treat Analysis | 1 | 2010 | 426 | 0.020 |
Why?
|
Angiography, Digital Subtraction | 1 | 2010 | 341 | 0.020 |
Why?
|
Methylprednisolone | 1 | 2010 | 387 | 0.020 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2019 | 1536 | 0.020 |
Why?
|
Odds Ratio | 2 | 2011 | 9849 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2011 | 868 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6933 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2011 | 1590 | 0.020 |
Why?
|
Survival Rate | 2 | 2013 | 12788 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2019 | 4803 | 0.020 |
Why?
|
Proteinuria | 1 | 2010 | 658 | 0.020 |
Why?
|
Prosthesis Failure | 1 | 2013 | 1206 | 0.020 |
Why?
|
Age of Onset | 1 | 2014 | 3271 | 0.020 |
Why?
|
Propensity Score | 1 | 2014 | 1781 | 0.020 |
Why?
|
Triiodobenzoic Acids | 1 | 2007 | 124 | 0.020 |
Why?
|
Child | 4 | 2023 | 77709 | 0.020 |
Why?
|
Antimalarials | 1 | 2014 | 905 | 0.020 |
Why?
|
Systole | 1 | 2010 | 958 | 0.020 |
Why?
|
Vasodilator Agents | 1 | 2011 | 977 | 0.020 |
Why?
|
Age Factors | 1 | 2004 | 18370 | 0.020 |
Why?
|
ROC Curve | 1 | 2015 | 3527 | 0.020 |
Why?
|
Exercise Tolerance | 1 | 2011 | 770 | 0.020 |
Why?
|
Pleural Diseases | 1 | 2007 | 139 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2011 | 1997 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2013 | 2110 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2011 | 2029 | 0.020 |
Why?
|
Health Resources | 1 | 2012 | 911 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2021 | 4931 | 0.020 |
Why?
|
Aortography | 1 | 2007 | 437 | 0.020 |
Why?
|
Asthma | 1 | 2004 | 6011 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2014 | 1855 | 0.020 |
Why?
|
Hematoma | 1 | 2010 | 758 | 0.020 |
Why?
|
Cerebral Infarction | 1 | 2010 | 1011 | 0.020 |
Why?
|
Sodium Chloride | 1 | 2007 | 625 | 0.020 |
Why?
|
Medical Records Systems, Computerized | 1 | 2011 | 1205 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2014 | 1637 | 0.020 |
Why?
|
Postoperative Period | 1 | 2010 | 1842 | 0.020 |
Why?
|
Gene Frequency | 1 | 2011 | 3588 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2010 | 1530 | 0.010 |
Why?
|
Reference Values | 1 | 2011 | 4982 | 0.010 |
Why?
|
Genome-Wide Association Study | 2 | 2013 | 12261 | 0.010 |
Why?
|
Treatment Failure | 1 | 2009 | 2618 | 0.010 |
Why?
|
Carotid Stenosis | 1 | 2010 | 854 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2008 | 1240 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2007 | 2124 | 0.010 |
Why?
|
Body Mass Index | 2 | 2011 | 12720 | 0.010 |
Why?
|
Hospitals | 1 | 2015 | 3952 | 0.010 |
Why?
|
Risk | 1 | 2013 | 9687 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2010 | 2107 | 0.010 |
Why?
|
Patient Selection | 1 | 2013 | 4215 | 0.010 |
Why?
|
Child, Preschool | 1 | 2023 | 41006 | 0.010 |
Why?
|
United States | 2 | 2013 | 69872 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4328 | 0.010 |
Why?
|
Rest | 1 | 2004 | 901 | 0.010 |
Why?
|
Computational Biology | 1 | 2011 | 3521 | 0.010 |
Why?
|
Vascular Diseases | 1 | 2007 | 1161 | 0.010 |
Why?
|
Length of Stay | 1 | 2012 | 6309 | 0.010 |
Why?
|
Health Care Costs | 1 | 2012 | 3209 | 0.010 |
Why?
|
Pulmonary Artery | 1 | 2007 | 1912 | 0.010 |
Why?
|
Calcinosis | 1 | 2007 | 1499 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2004 | 2373 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2013 | 9438 | 0.010 |
Why?
|
Electroencephalography | 1 | 2012 | 6150 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2006 | 6365 | 0.010 |
Why?
|
Insulin | 1 | 2011 | 6580 | 0.010 |
Why?
|
Models, Statistical | 1 | 2011 | 5102 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 29786 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2012 | 7659 | 0.010 |
Why?
|
Prevalence | 1 | 2008 | 15226 | 0.010 |
Why?
|
Quality of Life | 1 | 2011 | 12804 | 0.010 |
Why?
|